Inovio Pharmaceuticals Statistics
NASDAQ: INOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.12-0.04 (-3.46%)
Market open · Delayed 15 min · as of Oct 8, 2:53 PM ET
Inovio Pharmaceuticals by the numbers
Inovio Pharmaceuticals has a market capitalization of $115.3 million based on 103.40M shares outstanding. With trailing EPS of $-0.90, Inovio Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.3% below its 50-day average and 16.7% below its 200-day average.
Average daily trading volume is 3.83M shares, or about $4.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INO valuation vs. peer median
| Metric | INO | Peer median | Difference |
|---|---|---|---|
| Market cap | $115.29M | $122.68M | -6% |
| Avg. volume | 3.83M | 204.56K | +1771% |
Peer median across 8 companies: FHTX, VTVT, QUCY, COYA, HURA, NRXP, CLLS, BGM.
Valuation
- Market cap
- $115.29M
- EPS (TTM)
- $-0.90
- Shares outstanding
- 103.40M
Price and trading
- Previous close
- 1.16
- Open
- 1.17
- Day range
- 1.10 – 1.18
- 52-week range
- 0.56 – 2.72
- 52-week change
- -51.67%
- Beta
- —
- Volume
- 1.48M
- Average volume
- 3.83M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 115.29M
- Forward Pe
- -2.53
- Eps
- -0.90
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.72
- Week52 Low
- 0.56
- Avg Volume
- 3.83M
- Shares Outstanding
- 103.40M
- Ma50
- 1.12
- Ma200
- 1.34
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -59.01%
- Pct From52w Low
- 99.11%